Illumina to showcase the transformational impact of comprehensive genomic profiling in unlocking precision medicine for cancer patients, at ASCO

Go back to Illumina to showcase the transformational impact of comprehensive genomic profiling in unlocking precision medicine for cancer patients, at ASCO
Illumina, Inc. (NASDAQ: ILMN) Delayed: 191.20 +1.15 (0.61%)
Previous Close $190.05    52 Week High $196.47 
Open $189.17    52 Week Low $127.10 
Day High $194.18    P/E 212.44 
Day Low $187.09    EPS $0.90 
Volume 1,909,093